Food and Drug Administration

FILE - A sign for the Food and Drug Administration is seen in Silver Spring, Md., on Thursday, Dec. 10, 2020. On Wednesday, March 30, 2022, federal health advisers narrowly ruled against an experimental drug for the debilitating illness known as Lou Gehrig’s disease, a potential setback for patient groups who lobbied for the medication’s approval. A majority of advisers to the FDA voted 6-4 that a single study from Amylyx Pharmaceuticals failed to establish the drug's effectiveness in treating the deadly neurodegenerative disease known also as ALS, for amyotrophic lateral sclerosis. (AP Photo/Manuel Balce Ceneta)

FDA is told to tighten up its procedures for IT procurement

For the FDA, as for so many agencies, information technology is a big-ticket expenditure. The Health and Human Services inspector general examined FDA…

Read more

FDA looks to keep tabs on ‘common efforts’ to improve public health through master data management

Read more
Sunlight shines on the U.S. Capitol Dome in Washington, Friday, Jan. 7, 2022. (AP Photo/Patrick Semansky)

Biden signs continuing resolution into law averting government shutdown, FDA furloughs

Read more
FILE - This Aug. 2, 2018 file photo shows the U.S. Food and Drug Administration building behind FDA logos at a bus stop on the agency's campus in Silver Spring, Md. The Food and Drug Administration has issued a negative review of a closely watched experimental drug for the debilitating illness known as Lou Gehrig’s disease. The review comes ahead of a meeting this week for outside experts to vote on the drug for ALS. The drug has been the focal point of a lobbying campaign by patients, their families and lawmakers. FDA reviewers said Monday, March 28, 2022 the single study from Amylyx Pharmaceuticals was “not persuasive” due to missing data, errors in enrolling patients and other problems. (AP Photo/Jacquelyn Martin, File)

Deadline approaches to pass bill affecting employment for 3,500 FDA workers

Read more
Joshua Roberts

This FDA lawyer was instrumental in limits on cigarette marketing

Read more
Joshua Roberts

This FDA scientist’s work helps public health officials find sources of tainted food faster

Read more
FILE - This Oct. 14, 2015, file photo shows the Food and Drug Administration campus in Silver Spring, Md. On Tuesday, April 17, 2018, U.S. health officials proposed steps to improve the government’s system for overseeing medical devices, which has been subject to years of criticism for failing to catch problems with risky implants and medical instruments. (AP Photo/Andrew Harnik, File)

Medical devices are the soft cybersecurity underbelly for health care providers

For hackers, internet-connected medical devices have become an attractive target more vulnerabilities that stay unpatched compared to computers.

Read more
A due to limited supplies sign is shown on the baby formula shelf at a grocery store Tuesday, May 10, 2022, in Salt Lake City. Parents across much of the U.S. are scrambling to find baby formula after a combination of supply disruptions and safety recalls have swept many of the leading brands off store shelves. (AP Photo/Rick Bowmer)

Federal agencies’ roles in helping to solve the baby formula shortage

The Department of Health and Human Services has some new authorities to hopefully help resolve the nationwide shortage of baby formula.

Read more
Amelia Brust/Federal News Network

First HHS chief AI officer sees promise in 100 AI use cases, but challenges moving them forward

The Department of Health and Human Services’ first chief artificial intelligence officer no longer works in the federal government. But he says more agencies and health organizations are following his example, and naming their own chief AI officers.

Read more